Product Information

MONTELUKAST SOD 10 MG TABLET is a generic product labeled by Westminster Pharmaceuticals LLC, priced at $0.0432 per EA under NDC 69367028705. Its NADAC has been published 278 times since Jul 21, 2021.

FDA first approved this application on Jan 12, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MONTELUKAST SOD 10 MG TABLET

Montelukast Sodium
$0.0432per EA

Strength

10 mg/1

NDC

69367028705

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

MONTELUKAST SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA205683

FDA Approved

1/12/2016

TE Code

AB

On Market Since

5/30/2016

Pharmacological Classes

Leukotriene Receptor Antagonist
Leukotriene Receptor Antagonists

Price Statistics

The NADAC for MONTELUKAST SOD 10 MG TABLET has been published 278 times since Jul 21, 2021, and over the history we have for it it has declined 53.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0432 per EA
All-time high$0.0935 (Aug 11, 2021)
All-time low$0.0403 (Jul 22, 2026)
52-week high$0.0486
52-week low$0.0403
Median price$0.0584
Average price$0.0576
Largest weekly change-30.8% (Nov 20, 2024)
Weeks tracked278
Tracking sinceJul 21, 2021

Price History

1W

0.0%

1M

+3.1%

3M

+7.3%

6M

-0.6%

1Y

-15.7%

3Y

-32.9%

5Y

-41.1%

All

-53.8%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MONTELUKAST SOD 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MONTELUKAST SOD 10 MG TABLET, manufactured by Westminster Pharmaceuticals LLC, is $0.0432 per EA (NDC 69367028705), effective Nov 11, 2026.

How has the price of MONTELUKAST SOD 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for MONTELUKAST SOD 10 MG TABLET has declined 53.8%. It has been tracked across 278 weekly CMS publications since Jul 21, 2021.

What are the highest and lowest recorded NADAC prices for MONTELUKAST SOD 10 MG TABLET?

Since Jul 21, 2021, the NADAC for MONTELUKAST SOD 10 MG TABLET has ranged from a low of $0.0403 (Jul 22, 2026) to a high of $0.0935 (Aug 11, 2021), with a median of $0.0584 per EA.

Are there cheaper alternatives to MONTELUKAST SOD 10 MG TABLET?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MONTELUKAST SOD 10 MG TABLET, is $0.0425 per EA — about 2% below MONTELUKAST SOD 10 MG TABLET.

Who manufactures MONTELUKAST SOD 10 MG TABLET?

MONTELUKAST SOD 10 MG TABLET (NDC 69367028705) is labeled by Westminster Pharmaceuticals LLC, and CMS classifies it as a generic product.